A Centers for Disease Control and Prevention (CDC) committee has delayed its vote on whether or not to recommend lifting the pause of the Johnson & Johnson coronavirus vaccine. Two reports occurred during clinical trials and seven occurred after the vaccine was approved for emergency use authorization in February. 'ACIP does not wish to vote or put any motions on the table to vote on change to the current recommendation,' the committee wrote in a statement. The CDC's Advisory Committee on Immunization Practices is delaying its vote on recommending whether or not lift the pause of the Johnson & Johnson vaccine until more data are available. It echoes concerns voiced about the AstraZeneca-University of Oxford coronavirus vaccine, after Europe's drug regulator said there was possible link between the jab and rare blood clots.

Source: The Nation April 14, 2021 23:06 UTC